Intensity Therapeutics, Inc.
INTS
$1.94
$0.000.00%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.24M | 1.42M | 1.51M | 1.93M | 1.55M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.20M | 3.57M | 5.07M | 4.74M | 3.35M |
| Operating Income | -3.20M | -3.57M | -5.07M | -4.74M | -3.35M |
| Income Before Tax | -3.18M | -3.51M | -4.97M | -4.60M | -3.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -3.18M | -3.51M | -4.97M | -4.60M | -3.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -3.18M | -3.51M | -4.97M | -4.60M | -3.17M |
| EBIT | -3.20M | -3.57M | -5.07M | -4.74M | -3.35M |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | -0.22 | -0.25 | -0.36 | -0.34 | -0.23 |
| Normalized Basic EPS | -0.14 | -0.16 | -0.23 | -0.21 | -0.14 |
| EPS Diluted | -0.44 | -0.25 | -0.36 | -0.34 | -0.23 |
| Normalized Diluted EPS | -0.14 | -0.16 | -0.23 | -0.21 | -0.14 |
| Average Basic Shares Outstanding | 14.40M | 13.80M | 13.71M | 13.71M | 13.77M |
| Average Diluted Shares Outstanding | 14.40M | 13.80M | 13.71M | 13.71M | 13.77M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
